Carlos Cuevas

Carlos Cuevas

Auto-generated profile, based on publicly available information

Carlos Cuevas

University of Washington, Seattle, WA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2012 in Cancer Cell
Verified
Journal Article
Closed access
PPPaolo Provenzano
Paolo Provenzano
CCCarlos Cuevas
Carlos Cuevas
ACAmy E. Chang
Amy E. Chang
VGVikas K. Goel
Vikas K. Goel
DHDaniel D. Von Hoff
Daniel D. Von Hoff
SHSunil R. Hingorani
Sunil R. Hingorani

1 January 2008 in American Journal of Roentgenology
Verified
Journal Article
Closed access
TDTheodore J. Dubinsky
Theodore J. Dubinsky
CCCarlos Cuevas
Carlos Cuevas
MDManjiri K. Dighe
Manjiri K. Dighe
OKOrpheus Kolokythas
Orpheus Kolokythas
JHJoo Ha Hwang
Joo Ha Hwang
OBJECTIVE. The objective of this article is to introduce the reader to the principles and applications of high-intensity focused ultrasound (HIFU).CONCLUSION. Although a great deal about HIFU physics is understood, its clinical applications are currently limited, and multiple trials are underway worldwide to determine its efficacy.

20 February 2014 in Gut
Verified
Journal Article
Closed access
PDF file
ISIngunn M Stromnes
Ingunn M Stromnes
JBJ Scott Brockenbrough
J Scott Brockenbrough
KIKamel Izeradjene
Kamel Izeradjene
MCMarkus A Carlson
Markus A Carlson
CCCarlos Cuevas
Carlos Cuevas
SHSunil R Hingorani
Sunil R Hingorani
Background Pancreatic ductal adenocarcinoma (PDA) is characterised by a robust desmoplasia, including the notable accumulation of immunosuppressive cells that shield neoplastic cells from immune detection. Immune evasion may be further enhanced if the malignant cells fail to express high levels of antigens that are sufficiently immunogenic to engender an effector T cell response. Objective To investigate the predominant subsets of immunosuppressive cancer-conditioned myeloid cells that chronicle and shape the progression of pancreas cancer. We show that selective depletion of one subset of myeloid-derived suppressor cells (MDSC) in an autochthonous, genetically engineered mouse model (GEMM) of PDA unmasks the ability of the adaptive immune response to engage and target tumour epithelial cells. Methods A combination of in vivo and in vitro studies were performed employing a GEMM that faithfully recapitulates the cardinal features of human PDA. The predominant cancer-conditioned myeloid cell subpopulation was specifically targeted in vivo and the biological outcomes determined. Results PDA orchestrates the induction of distinct subsets of cancer-associated myeloid cells through the production of factors known to influence myelopoiesis. These immature myeloid cells inhibit the proliferation and induce apoptosis of activated T cells. Targeted depletion of granulocytic MDSC (Gr-MDSC) in autochthonous PDA increases the intratumoral accumulation of activated CD8 T cells and apoptosis of tumour epithelial cells and also remodels the tumour stroma. Conclusions Neoplastic ductal cells of the pancreas induce distinct myeloid cell subsets that promote tumour cell survival and accumulation. Targeted depletion of a single myeloid subset, the Gr-MDSC, can unmask an endogenous T cell response, disclosing an unexpected latent immunity and invoking targeting of Gr-MDSC as a potential strategy to exploit for treating this highly lethal disease.

1 July 2011 in RadioGraphics
Verified
Journal Article
Closed access
PRPrabhakar Rajiah
Prabhakar Rajiah
RSRakesh Sinha
Rakesh Sinha
CCCarlos Cuevas
Carlos Cuevas
TDTheodore J. Dubinsky
Theodore J. Dubinsky
WBWilliam H. Bush
William H. Bush
OKOrpheus Kolokythas
Orpheus Kolokythas
Retroperitoneal masses not arising from major solid organs are uncommon. Although there is no simple method of classifying retroperitoneal masses, a reasonable approach is to consider the masses as predominantly solid or cystic and to subdivide these into neoplastic and nonneoplastic masses. Because the treatment options vary, it is useful to be able to differentiate these masses by using imaging criteria. Although the differential diagnosis of retroperitoneal masses can be narrowed down to a certain extent on the basis of imaging characteristics, patterns of involvement, and demographics, there is still a considerable overlap of imaging findings for these masses, and histologic examination is often required for definitive diagnosis. Computed tomography (CT) and magnetic resonance (MR) imaging play an important role in characterization and in the assessment of the extent of the disease and involvement of adjacent and distant structures. Familiarity with the CT and MR imaging features of various retroperitoneal masses will facilitate accurate diagnosis and staging for aggressive lesions.

1 May 2006 in Current Problems in Diagnostic Radiology
Verified
Journal Article
Closed access
CCCarlos Cuevas
Carlos Cuevas
MRMolly Raske
Molly Raske
WBWilliam H. Bush
William H. Bush
TTThomas Takayama
Thomas Takayama
JMJeffrey H. Maki
Jeffrey H. Maki
EMEmily Meshberg
Emily Meshberg

11 March 2008 in Journal of Clinical Ultrasound
Verified
Journal Article
Closed access
PDF file
MDManjiri Dighe
Manjiri Dighe
CCCarlos Cuevas
Carlos Cuevas
MMMariam Moshiri
Mariam Moshiri
TDTheodore Dubinsky
Theodore Dubinsky
Vikram Singh DograVikram Singh Dogra
Vikram Singh Dogra